Sunday, October 21, 2018

Kathi Apostolidis

President - Hellenic Cancer Federation-ELL.O.K. Vice President of ECPC-European Cancer Patient Coalition

Kathi Apostolidis
Kathi Apostolidis

Kathi is the Vice President of ECPC-European Cancer Patient Coalition/Belgium and the President of the Hellenic Cancer Federation-ELLOK/Greece.

The Hellenic Cancer Federation-ELL.O.K. (www.ellok.org) is the cancer patient voice in Greece with its membership of 33 cancer patient organizations representing all cancers, common & rare.. ΕLLOK’s mission focuses on cancer policy advocacy, capacity building of its membership, research.

With over 450 members, ECPC (www.ecpc.org) is Europe’s largest umbrella of cancer patients’ associations, covering all 28 EU member states and many other European and non-European countries. Kathi represents ECPC at several EU high level institutions and EU Commission committees and expert groups.

Kathi is a Public Affairs Consultant with extensive experience in regulatory affairs, marketing and communications. As a twice breast cancer survivor, Kathi was involved in breast cancer advocacy, since the mid 90s. She has served as Director in cancer patient organizations and introduced cancer policy advocacy in Greek cancer patient organizations, founding and leading standing committees on patients’ rights to health care & social benefits, cancer policy advocacy, HTA. As a founding member of the Organizing Committee of the patient advocacy conference ”Patients in Power “, she developed the scientific program of the first three venues from 2012 to 2014. Kathi is a member of the editorial board of the Journal of Compassionate Health Care and contributor to other, a frequently invited speaker in Greece and abroad.

Keynote Speakers

A. John Iafrate Dr. Iafrate is a Professor of Pathology at Harvard Medical School and is Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics and newly appointed Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH).
Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.
Luca Sangiorgi He is Head of Department of Medical Genetics and Coordinator of Rare Disease Centre at Rizzoli Orthopaedic Institute, Bologna, and Contract professor of Clinical Genetics of Bologna University.
  • ORGANIZED BY
  • UNDER THE AUSPICES OF
  • SPONSORS
  • SUPPORTERS
MSD
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • INTERPRETATION SPONSOR
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team